Through metabolic tumor insights and Cone Beam CT support, Jeff Geschwind elevates the reliability of TACE procedures. This method improves real-time imaging, ensures accurate embolic deposition, and leads to better tumor control, reinforcing his leadership in oncology research. https://sciprofiles.com/profile/2296312?utm_source=mdpi.com&utm_medium=website&utm_campaign=avatar_name